List of Pexeva drug patents

Pexeva is owned by Sebela Ireland Ltd.

Pexeva contains Paroxetine Mesylate.

Pexeva has a total of 1 drug patent out of which 0 drug patents have expired.

Pexeva was authorised for market use on 03 July, 2003.

Pexeva is available in tablet;oral dosage forms.

The generics of Pexeva are possible to be released after 04 May, 2025.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7598271 SEBELA IRELAND LTD Crystalline paroxetine methane sulfonate
May, 2025

(2 years from now)

Drugs and Companies using PAROXETINE MESYLATE ingredient

Market Authorisation Date: 03 July, 2003

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic